Evidence map›Paper›PMID 38149098›Full record

ReviewFrontiers in endocrinology2023

The role of the hypothalamic-pituitary-adrenal axis in depression across the female reproductive lifecycle: current knowledge and future directions.

Liisa Hantsoo, Kathleen M Jagodnik, Andrew M Novick, Ritika Baweja, Teresa Lanza di Scalea, Aysegul Ozerdem, Erin C McGlade, Diana I Simeonova, Sharon Dekel, Sara L Kornfield and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
21.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Heart-Brain Axis: Subclinical Cardiovascular Changes and Brain Health.Journal of the American Heart Association · 2026
    Review
  19. Article
  20. Psychedelic therapy and postpartum depression: priorities and prospects.Therapeutic advances in psychopharmacology · 2026
    Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 12 institutions in 1 country.

Liisa HantsooDepartment of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Kathleen M JagodnikDepartment of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston, MA, United States.
Andrew M NovickDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Ritika BawejaDepartment of Psychiatry and Behavioral Health, Penn State Health, Hershey, PA, United States.
Teresa Lanza di ScaleaDepartment of Psychiatry and Behavioral Sciences, Dell Medical School, University of Texas at Austin, Austin, TX, United States.
Aysegul OzerdemDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
Erin C McGladeDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah School of Medicine, Salt Lake, UT, United States.
Diana I SimeonovaDepartment of Psychiatry and Behavioral Sciences, Brain Health Center, Emory University School of Medicine, Atlanta, GA, United States.
Sharon DekelDepartment of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston, MA, United States.
Sara L KornfieldCenter for Women's Behavioral Wellness, Psychiatry Department, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Michelle NazarethDepartment of Neuroscience, The Johns Hopkins University, Baltimore, MD, United States.
Sandra J WeissDepartment of Community Health Systems, University of California, San Francisco, San Francisco, CA, United States.
Emory University · USHarvard University · USJohns Hopkins Medicine · USJohns Hopkins University · USMassachusetts General Hospital · USMayo Clinic · USPenn State Milton S. Hershey Medical Center · USThe University of Texas at Austin · USUniversity of California, San Francisco · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Pennsylvania · USUniversity of Utah · US

Funding

Prospective Research Studies of Maturation (PRISM)- Research ProjectU01DA041134 · NIDA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI ERIN MCGLADE, PERRY FRANKLIN RENSHAW · 2015 to 2026
$29.2M
Suppression of ERalpha in Hematopoietic Stem Cell-Derived Adipocytes Increases Adiposity via Kynurenine and the Aryl Hydrocarbon ReceptorU54AG062319 · NIA · UNIVERSITY OF COLORADO DENVER · PI Wendy M Kohrt · 2018 to 2026
$13.5M
Defining postpartum PTSD and its implications for maternal wellness and child developmentR01HD108619 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI Sharon Dekel · 2022 to 2026
$3.7M
Antenatal Corticosteroids, Maternal Depression and Preterm Infant Stress ResponseR01HD081188 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, SANDRA JEAN · 2015 to 2019
$2.9M
Perinatal Precursors of Early Microbiome Development.R01HD102604 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LYNCH, SUSAN VERONICA, WEISS, SANDRA JEAN · 2020 to 2023
$2.6M
Neurobiology of hormonal contraceptionK23HD110435 · NICHD · UNIVERSITY OF COLORADO DENVER · PI Andrew Michael Novick · 2023 to 2026
$643k
Resilience in High-Risk Offspring of Mothers with Bipolar DisorderK23MH096042 · NIMH · EMORY UNIVERSITY · PI SIMEONOVA, DIANA IORGOVA · 2012 to 2015
$618k
Allopregnanolone and Gamma-Aminobutyric Acid Receptor (GABA-A-R) Plasticity in Women with Premenstrual Mood SymptomsR21MH125936 · NIMH · JOHNS HOPKINS UNIVERSITY · PI HANTSOO, LIISA VICTORIA, PINNA, GRAZIANO · 2022 to 2023
$461k
Predictive modeling of peripartum depressionR03HD101724 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI DEKEL, SHARON · 2020 to 2021
$168k
NIA NIH HHS U54 AG062319NICHD NIH HHS K23 HD110435NICHD NIH HHS L30 HD106379NICHD NIH HHS R01 HD081188NICHD NIH HHS R01 HD102604NICHD NIH HHS R01 HD108619NICHD NIH HHS R03 HD101724NIDA NIH HHS U01 DA041134NIMH NIH HHS K23 MH096042NIMH NIH HHS R21 MH125936
6 · The paper itself

Abstract

The aim of this narrative review is to consolidate knowledge on the role of the hypothalamic-pituitary-adrenal (HPA) axis in depression pathophysiology at different reproductive stages across the female lifespan. Despite growing evidence about the impact of gonadal hormones on mood disorders, no previous review has examined the interaction between such hormonal changes and the HPA axis within the context of depressive disorders in women. We will focus on HPA axis function in depressive disorders at different reproductive stages including the menstrual cycle (e.g., premenstrual dysphoric disorder [PMDD]), perinatally (e.g., postpartum depression), and in perimenopausal depression. Each of these reproductive stages is characterized by vast physiological changes and presents major neuroendocrine reorganization. The HPA axis is one of the main targets of such functional alterations, and with its key role in stress response, it is an etiological factor in vulnerable windows for depression across the female lifespan. We begin with an overview of the HPA axis and a brief summary of techniques for measuring HPA axis parameters. We then describe the hormonal milieu of each of these key reproductive stages, and integrate information about HPA axis function in depression across these reproductive stages, describing similarities and differences. The role of a history of stress and trauma exposure as a contributor to female depression in the context of HPA axis involvement across the reproductive stages is also presented. This review advances the pursuit of understanding common biological mechanisms across depressive disorders among women. Our overarching goal is to identify unmet needs in characterizing stress-related markers of depression in women in the context of hormonal changes across the lifespan, and to support future research in women's mental health as it pertains to pathophysiology, early diagnosis, and treatment targets.

Indexed as

DepressionPremenstrual Dysphoric DisorderAnimalsFemaleHumansHypothalamo-Hypophyseal SystemLife Cycle StagesMenstrual CyclePituitary-Adrenal Systemdepressionfemalehypothalamic-pituitary-adrenal (HPA) axisperimenopauseperipartumpremenstrualstresstrauma

Identifiers

PMID38149098
PMCPMC10750128
OpenAlexW4389627412

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.